Effects of Fibrin Sealant on Seroma Reduction for Patients with Breast Cancer Undergoing Axillary Dissection: Meta-Analysis of Randomized Controlled Trials.
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
23
04
2020
pubmed:
22
6
2020
medline:
28
4
2021
entrez:
22
6
2020
Statut:
ppublish
Résumé
Seroma formation is common in patients with breast cancer after axillary dissection. Fibrin sealant, containing fibrinogen and thrombin, has been developed to improve wound healing. We conducted a systematic review and meta-analysis to evaluate the efficacy of fibrin sealants in reducing seroma among patients with breast cancer undergoing axillary dissection. We searched the PubMed, EMBASE, and Cochrane Library databases for randomized controlled trials (RCTs) published up to April 2020. Pooled estimates of the outcomes were computed using a random-effects model. The primary outcomes were incidence and volume of seroma, while the secondary outcomes were volume and duration of drainage, incidence of infection, and length of hospital stay. We reviewed 23 RCTs that included 1640 patients. Compared with the control group, the fibrin sealant group had no significant differences in the incidence of seroma, length of hospital stay, or incidence of surgical site infection. Significant intergroup differences were discovered in lower volume of seroma (weighted mean difference [WMD] - 71.88, 95% confidence interval [CI] - 135.58 to - 8.19), volume of drainage (WMD - 73.24, 95% CI - 107.32 to - 39.15), and duration of drainage (WMD - 0.84, 95% CI - 1.50 to - 0.19). Fibrin sealants provide limited benefits in reducing the volume of seroma and the volume and duration of drainage. Therefore, after shared decision making, surgeons may apply fibrin sealants to patients with breast cancer undergoing axillary dissection.
Sections du résumé
BACKGROUND
BACKGROUND
Seroma formation is common in patients with breast cancer after axillary dissection. Fibrin sealant, containing fibrinogen and thrombin, has been developed to improve wound healing. We conducted a systematic review and meta-analysis to evaluate the efficacy of fibrin sealants in reducing seroma among patients with breast cancer undergoing axillary dissection.
METHODS
METHODS
We searched the PubMed, EMBASE, and Cochrane Library databases for randomized controlled trials (RCTs) published up to April 2020. Pooled estimates of the outcomes were computed using a random-effects model. The primary outcomes were incidence and volume of seroma, while the secondary outcomes were volume and duration of drainage, incidence of infection, and length of hospital stay.
RESULTS
RESULTS
We reviewed 23 RCTs that included 1640 patients. Compared with the control group, the fibrin sealant group had no significant differences in the incidence of seroma, length of hospital stay, or incidence of surgical site infection. Significant intergroup differences were discovered in lower volume of seroma (weighted mean difference [WMD] - 71.88, 95% confidence interval [CI] - 135.58 to - 8.19), volume of drainage (WMD - 73.24, 95% CI - 107.32 to - 39.15), and duration of drainage (WMD - 0.84, 95% CI - 1.50 to - 0.19).
CONCLUSIONS
CONCLUSIONS
Fibrin sealants provide limited benefits in reducing the volume of seroma and the volume and duration of drainage. Therefore, after shared decision making, surgeons may apply fibrin sealants to patients with breast cancer undergoing axillary dissection.
Identifiants
pubmed: 32564232
doi: 10.1245/s10434-020-08747-5
pii: 10.1245/s10434-020-08747-5
doi:
Substances chimiques
Fibrin Tissue Adhesive
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
5286-5295Subventions
Organisme : Yuan's General Hospital
ID : 108YGH-TMU-06
Références
Hashemi E, Kaviani A, Najafi M, Ebrahimi M, Hooshmand H, Montazeri A. Seroma formation after surgery for breast cancer. World J Surg Oncol. 2004;2:44.
pubmed: 15588301
pmcid: 543447
doi: 10.1186/1477-7819-2-44
Roses DF, Brooks AD, Harris MN, Shapiro RL, Mitnick J. Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg. 1999;230:194–201.
pubmed: 10450733
pmcid: 1420861
doi: 10.1097/00000658-199908000-00009
Cipolla C, Fricano S, Vieni S, et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. J Surg Oncol. 2010;101:600–3.
pubmed: 20461767
doi: 10.1002/jso.21531
Woodworth PA, McBoyle MF, Helmer SD, Beamer RL. Seroma formation after breast cancer surgery: incidence and predicting factors. Am Surg. 2000;66:444–50; discussion 450–1.
Vasileiadou K, Kosmidis C, Anthimidis G, Miliaras S, Kostopoulos I, Fahantidis E. Cyanoacrylate adhesive reduces seroma production after modified radical mastectomy or quadrantectomy with lymph node dissection-a prospective randomized clinical trial. Clin Breast Cancer. 2017;17:595–600.
pubmed: 28673765
doi: 10.1016/j.clbc.2017.04.004
Chaturvedi P, Chaturvedi U. Axillary compression with delayed drain removal reduces prolonged seroma formation. J Surg Oncol. 2001;78:279–80.
pubmed: 11745825
doi: 10.1002/jso.1168
Galatius H, Okholm M, Hoffmann J. Mastectomy using ultrasonic dissection: effect on seroma formation. Breast. 2003;12:338–41.
pubmed: 14659149
doi: 10.1016/S0960-9776(03)00110-3
Rice DC, Morris SM, Sarr MG, et al. Intraoperative topical tetracycline sclerotherapy following mastectomy: a prospective, randomized trial. J Surg Oncol. 2000;73:224–7.
pubmed: 10797336
doi: 10.1002/(SICI)1096-9098(200004)73:4<224::AID-JSO7>3.0.CO;2-0
Talbot ML, Magarey CJ. Reduced use of drains following axillary lymphadenectomy for breast cancer. ANZ J Surg. 2002;72:488–90.
pubmed: 12123509
doi: 10.1046/j.1445-2197.2002.02456.x
Spotnitz WD. Fibrin Sealant: The only approved hemostat, sealant, and adhesive: a laboratory and clinical perspective. ISRN Surg. 2014;2014:203943.
pubmed: 24729902
pmcid: 3960746
doi: 10.1155/2014/203943
Langer S, Guenther JM, DiFronzo LA. Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer? Am Surg. 2003;69:77–81.
pubmed: 12575787
Moore MM, Nguyen DHD, Spotnitz WD. Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. Am Surg. 1997;63:97–102.
pubmed: 8985079
Sajid MS, Hutson KH, Rapisarda IF, Bonomi R. Fibrin glue instillation under skin flaps to prevent seroma‐related morbidity following breast and axillary surgery. Cochrane Database Syst Rev. 2013;(5):CD009557.
Turner EJ, Benson JR, Winters ZE. Techniques in the prevention and management of seromas after breast surgery. Future Oncol. 2014;10:1049–63.
pubmed: 24941989
doi: 10.2217/fon.13.257
Benevento R, Santoriello A, Pellino G, et al. The effects of low-thrombin fibrin sealant on wound serous drainage, seroma formation and length of postoperative stay in patients undergoing axillary node dissection for breast cancer. A randomized controlled trial. Int J Surg. 2014;12:1210–5.
pubmed: 25462702
doi: 10.1016/j.ijsu.2014.10.005
Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available at: www.cochrane-handbook.org .
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
pubmed: 2714672
pmcid: 2714672
doi: 10.1136/bmj.b2700
Wan X. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
pubmed: 25524443
pmcid: 4383202
doi: 10.1186/1471-2288-14-135
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
pubmed: 3802833
doi: 10.1016/0197-2456(86)90046-2
Segura-Castillo JL, Estrada-Rivera O, Castro-Cervantes JM, Cortés-Flores AO, Velázquez-Ramírez GA, González-Ojeda A. Reducción del drenaje linfático posterior a mastectomía radical modificada con la aplicación de gel de fibrina. Cir Cir. 2005;73:345–50.
pubmed: 16336797
Gioffere Florio MA, Mezzasalma F, Manganaro T, Pakravanan H, Cogliandolo A. L’impiego della colla di fibrina nella chirurgia del carcinoma della mammella. Giorn Chir. 1993;14:239–41.
Berger A, Tempfer C, Hartmann B, et al. Sealing of postoperative axillary leakage after axillary lymphadenectomy using a fibrin glue coated collagen patch: a prospective randomised study. Breast Cancer Res Treat. 2001;67:9–14.
pubmed: 11518470
doi: 10.1023/A:1010671209279
Dinsmore RC, Harris JA, Gustafson RJ. Effect of Fibrin glue on lymphatic drainage after modified radical mastectomy: a prospetive ramdomized trial. Am Surg. 2000;66:982–5.
pubmed: 11261630
El Nakeeb A. Influence of fibrin glue on seroma formation after modified radical mastectomy: a prospective randomized study. Breast J. 2009;15:671–2.
pubmed: 19558542
doi: 10.1111/j.1524-4741.2009.00801.x
Gilly FN, François Y, Sayag-Beaujard AC, Glehen O, Brachet A, Vignal J. Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. Eur Surg Res. 1998;30:439–43.
pubmed: 9838238
doi: 10.1159/000008611
Fawzy A, Gaber A, Farid AAM. Role of fibrin glue in seroma reduction after modified radical mastectomy. International Surgery Journal. 2017;4:2103–9.
doi: 10.18203/2349-2902.isj20172579
Jain PK, Sowdi R, Anderson AD, MacFie J. Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. Br J Surg. 2004;91:54–60.
pubmed: 14716794
doi: 10.1002/bjs.4435
Ko E, Han W, Cho J, et al. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. J Korean Med Sci. 2009;24:92–6.
pubmed: 19270819
pmcid: 2650992
doi: 10.3346/jkms.2009.24.1.92
Moore M, Burak WE Jr, Nelson E, et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. J Am Coll Surg. 2001;192:591–9.
pubmed: 11333096
doi: 10.1016/S1072-7515(01)00827-4
Miri Bonjar MR, Maghsoudi H, Samnia R, Saleh P, Parsafar F. Efficacy of fibrin glue on seroma formation after breast surgery. Int J Breast Cancer. 2012;2012:643132.
pubmed: 23008776
pmcid: 3447350
doi: 10.1155/2012/643132
Moore MM. Fibrin Sealant reduces drainage and allows for earlier drain removal after axillary dissection: a Randomized prospective trial. Am Surg. 1997;63:97–102.
pubmed: 8985079
Mustonen PK, Härmä MA, Eskelinen MJ. The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scand J Surg. 2004;93:209–12.
pubmed: 15544076
doi: 10.1177/145749690409300307
Ruggiero R, Procaccini E, Gili S, et al. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer. G Chir. 2009;30:306–10.
pubmed: 19580713
Ruggiero R, Docimo G, Gubitosi A, et al. Axillary lymphadenectomy for breast cancer and fibrin glue. Ann Ital Chir. 2014;85:88–92.
pubmed: 23080086
Tasinato R. Prevention of axillary seromas in patients who underwent limphadenectomy for breast cancer. Acta Chir Ital. 1993;49:479–84.
Udén P, Aspegren K, Balldin G, Garne JP, Larsson SA. Fibrin adhesive in radical mastectomy. Eur J Surg. 1993;159:263–5.
pubmed: 8103359
Ulusoy AN, Polat C, Alvur M, Kandemir B, Bulut F. Effect of fibrin glue on lymphatic drainage and on drain removal time after modified radical mastectomy: a prospective randomized study. Breast J. 2003;9:393–6.
pubmed: 12968960
doi: 10.1046/j.1524-4741.2003.09506.x
Vaxman F, Kolbe A, Stricher F, et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. Eur Surg Res. 1995;27:346–52.
pubmed: 7589007
doi: 10.1159/000129419
Weber WP, Tausch C, Hayoz S, et al. Impact of a surgical sealing patch on lymphatic drainage after axillary dissection for breast cancer: the SAKK 23/13 multicenter randomized phase III trial. Ann Surg Oncol. 2018;25:2632–40.
pubmed: 29948418
doi: 10.1245/s10434-018-6556-9
Covarelli P, Barberini F, Cannavicci D, et al. Reduction of postoperative lymphorrhoea in patients undergoing radical lymphadenectomy for stage III melanoma: prospective study using collagen-fibrin patches. Minerva Chir. 2020;75:111–6.
pubmed: 31820617
doi: 10.23736/S0026-4733.19.08114-8
Kim HC, Choi C, Kim WY. Effectiveness of fibrin sealant patch in reducing drain volume after pelvic lymph node dissection in women with gynecologic malignancy. Biomed Res Int. 2017;2017:3086857.
pubmed: 29279844
pmcid: 5723939
Eichler C, Fischer P, Sauerwald A, Dahdouh F, Warm M. Flap adhesion and effect on postoperative complication rates using Tissuglu® in mastectomy patients. Breast Cancer. 2016;23:486–90.
pubmed: 25874687
doi: 10.1007/s12282-015-0591-1
Llewellyn-Bennett R, Greenwood R, Benson JR, et al. Randomized clinical trial on the effect of fibrin sealant on latissimus dorsi donor-site seroma formation after breast reconstruction. Br J Surg. 2012;99:1381–8.
pubmed: 22961517
doi: 10.1002/bjs.8874
van Bastelaar J, Theunissen LLB, Snoeijs MGJ, Beets GL, Vissers YLJ. Flap fixation using tissue glue or sutures appears to reduce seroma aspiration after mastectomy for breast cancer. Clin Breast Cancer. 2017;17:316–21.
pubmed: 28202253
doi: 10.1016/j.clbc.2017.01.005